Wells Fargo’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $547K | Buy |
23,683
+8,338
| +54% | +$193K | ﹤0.01% | 3725 |
|
|
2025
Q1 | $414K | Buy |
15,345
+2,094
| +16% | +$56.5K | ﹤0.01% | 3802 |
|
|
2024
Q4 | $709K | Buy |
13,251
+4,585
| +53% | +$245K | ﹤0.01% | 3497 |
|
|
2024
Q3 | $394K | Sell |
8,666
-341
| -4% | -$15.5K | ﹤0.01% | 3774 |
|
|
2024
Q2 | $377K | Buy |
9,007
+2,907
| +48% | +$122K | ﹤0.01% | 3745 |
|
|
2024
Q1 | $230K | Buy |
6,100
+812
| +15% | +$30.6K | ﹤0.01% | 4026 |
|
|
2023
Q4 | $56.7K | Buy |
5,288
+1,023
| +24% | +$11K | ﹤0.01% | 4809 |
|
|
2023
Q3 | $43K | Sell |
4,265
-2,368
| -36% | -$23.9K | ﹤0.01% | 4906 |
|
|
2023
Q2 | $78.7K | Buy |
6,633
+3,548
| +115% | +$42.1K | ﹤0.01% | 4908 |
|
|
2023
Q1 | $37.3K | Buy |
+3,085
| New | +$37.3K | ﹤0.01% | 5027 |
|
|
2022
Q4 | – | Sell |
-45
| Closed | -$1K | – | 7245 |
|
|
2022
Q3 | $1K | Sell |
45
-29,595
| -100% | -$658K | ﹤0.01% | 6037 |
|
|
2022
Q2 | $362K | Buy |
29,640
+24,898
| +525% | +$304K | ﹤0.01% | 3710 |
|
|
2022
Q1 | $68K | Sell |
4,742
-3,481
| -42% | -$49.9K | ﹤0.01% | 5186 |
|
|
2021
Q4 | $163K | Buy |
8,223
+8,149
| +11,012% | +$162K | ﹤0.01% | 5004 |
|
|
2021
Q3 | $2K | Buy |
+74
| New | +$2K | ﹤0.01% | 6241 |
|